Gu‐Qing Zeng

1.4k total citations · 1 hit paper
29 papers, 1.2k citations indexed

About

Gu‐Qing Zeng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Gu‐Qing Zeng has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Gu‐Qing Zeng's work include S100 Proteins and Annexins (6 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (4 papers). Gu‐Qing Zeng is often cited by papers focused on S100 Proteins and Annexins (6 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (4 papers). Gu‐Qing Zeng collaborates with scholars based in China, United States and Saudi Arabia. Gu‐Qing Zeng's co-authors include Michael J. Quon, Maoyu Li, Zhi‐Qiang Xiao, Jia‐Quan Qu, Hong Yi, Xun‐Xun Wan, Jianhuang Li, Qiu‐Yan He, Xia Li and Yu Chen and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gu‐Qing Zeng

27 papers receiving 1.1k citations

Hit Papers

Insulin-stimulated produc... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gu‐Qing Zeng China 14 573 291 232 187 178 29 1.2k
James P. Stice United States 15 619 1.1× 170 0.6× 189 0.8× 125 0.7× 98 0.6× 20 1.1k
Ryan D. Sheldon United States 20 522 0.9× 310 1.1× 141 0.6× 120 0.6× 192 1.1× 59 1.2k
M. Julia Brosnan United States 20 654 1.1× 458 1.6× 208 0.9× 210 1.1× 121 0.7× 27 1.6k
Anne‐Laure Guihot France 20 456 0.8× 219 0.8× 238 1.0× 215 1.1× 82 0.5× 38 1.1k
Danielle A. Guimarães Brazil 23 330 0.6× 335 1.2× 371 1.6× 125 0.7× 220 1.2× 39 1.1k
Tomas Welbourne United States 19 592 1.0× 224 0.8× 134 0.6× 182 1.0× 175 1.0× 49 1.4k
Naoko Iino Japan 16 563 1.0× 147 0.5× 223 1.0× 165 0.9× 143 0.8× 23 1.0k
Jingzhou Chen China 22 709 1.2× 162 0.6× 428 1.8× 117 0.6× 299 1.7× 84 1.5k
Michiel Adriaens Netherlands 18 715 1.2× 181 0.6× 92 0.4× 98 0.5× 245 1.4× 57 1.3k

Countries citing papers authored by Gu‐Qing Zeng

Since Specialization
Citations

This map shows the geographic impact of Gu‐Qing Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu‐Qing Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu‐Qing Zeng more than expected).

Fields of papers citing papers by Gu‐Qing Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gu‐Qing Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu‐Qing Zeng. The network helps show where Gu‐Qing Zeng may publish in the future.

Co-authorship network of co-authors of Gu‐Qing Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Gu‐Qing Zeng. A scholar is included among the top collaborators of Gu‐Qing Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gu‐Qing Zeng. Gu‐Qing Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Zeng, Gu‐Qing, et al.. (2019). Awareness and knowledge of human papillomavirus vaccination and their influential factors among Chinese women: a systematic review. SHILAP Revista de lepidopterología. 6(4). 317–326. 3 indexed citations
4.
Wan, Yanping, et al.. (2018). Effect of Resourcefulness Training on Symptoms Distress of Patients with Nasopharyngeal Carcinoma. Medical Science Monitor. 24. 5624–5634. 3 indexed citations
5.
Huang, Weiguo, Yafei Wang, Gu‐Qing Zeng, et al.. (2017). Study the effect of CTSD interaction proteins in invasion and metastasis of nasopharyngeal carcinoma. Translational Cancer Research. 6(6). 1236–1247. 1 indexed citations
6.
Liao, Li, Yanping Wan, Meixiang Li, et al.. (2016). Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma. World Journal of Surgical Oncology. 14(1). 70–70. 18 indexed citations
7.
Huang, Lifang, Li Liao, Yanping Wan, et al.. (2016). Downregulation of Annexin A1 is correlated with radioresistance in nasopharyngeal carcinoma. Oncology Letters. 12(6). 5229–5234. 19 indexed citations
8.
Liu, Aifeng, Weiguo Huang, Gu‐Qing Zeng, et al.. (2014). Expression of the Annexin A1 gene is associated with suppression of growth, invasion and metastasis of nasopharyngeal carcinoma. Molecular Medicine Reports. 10(6). 3059–3067. 24 indexed citations
9.
Zeng, Gu‐Qing, Hong Yi, Pengfei Zhang, et al.. (2013). The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process. PLoS ONE. 8(8). e71865–e71865. 24 indexed citations
10.
Tang, Jie, Junjun Li, Gu‐Qing Zeng, et al.. (2013). Antisense oligonucleotide suppression of human IGF-1R inhibits the growth and survival of in vitro cultured epithelial ovarian cancer cells. Journal of Ovarian Research. 6(1). 71–71. 12 indexed citations
11.
Zeng, Gu‐Qing, Ailan Cheng, Jie Tang, et al.. (2013). Annexin A1: A new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Medical Hypotheses. 81(1). 68–70. 11 indexed citations
12.
Zeng, Gu‐Qing, Pengfei Zhang, Xingming Deng, et al.. (2012). Identification of Candidate Biomarkers for Early Detection of Human Lung Squamous Cell Cancer by Quantitative Proteomics. Molecular & Cellular Proteomics. 11(6). M111.013946–M111.013946. 56 indexed citations
13.
Zhang, Pengfei, Gu‐Qing Zeng, Rong Hu, et al.. (2012). Identification of Flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis. Journal of Proteomics. 77. 202–214. 31 indexed citations
14.
Zuo, Jianhong, Wei Zhu, Maoyu Li, et al.. (2011). Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin. Journal of Cellular Biochemistry. 112(9). 2508–2517. 214 indexed citations
15.
Zeng, Gu‐Qing, Hong Yi, Xinhui Li, et al.. (2011). Identification of the proteins related to p53-mediated radioresponse in nasopharyngeal carcinoma by proteomic analysis. Journal of Proteomics. 74(12). 2723–2733. 21 indexed citations
16.
Xiao, Yanhua, Xia Li, Tan Tan, et al.. (2011). Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis. Journal of Cancer Research and Clinical Oncology. 137(12). 1831–1840. 14 indexed citations
17.
Ruan, Lin, Xinhui Li, Xun‐Xun Wan, et al.. (2011). Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. Proteome Science. 9(1). 35–35. 29 indexed citations
18.
Deng, Youchao, et al.. (2007). A new flavonol from Sophora tonkinensis. Journal of Asian Natural Products Research. 9(1). 45–48. 18 indexed citations
19.
Zeng, Gu‐Qing, et al.. (2000). [Study of CFTR gene mutation in Chinese CUAVD patients].. PubMed. 17(4). 241–3. 4 indexed citations
20.
Zeng, Gu‐Qing & Michael J. Quon. (1996). Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.. Journal of Clinical Investigation. 98(4). 894–898. 590 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026